(S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NN skin) (NN microvasculature) (NN angiogenesis)) (, ,) (NP (NN cell) (NN migration)) (, ,) (CC and) (NP (NN permeability)))) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN inhibitor)) (PP (IN of) (NP (NN PKCalpha))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))))) (VP (VBZ induces) (NP (JJ phenotypic) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN morphology)) (PP (IN of) (NP (NP (JJ microvascular) (JJ endothelial) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (JJ major) (NNS functions)) (PP (IN of) (NP (DT the) (NN microvasculature))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS functions)) (VP (VBP include) (NP (NP (DT the) (JJ first) (NNS stages)) (PP (IN of) (NP (NN sprouting))) (PP (IN in) (NP (NP (NN angiogenesis)) (, ,) (NP (NP (NN cell) (NN migration)) (VP (VBG following) (NP (NN wounding)))) (, ,) (CC and) (NP (JJ vascular) (NN permeability))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ specific) (NN isoform-LRB-s-RRB-)) (PP (IN of) (NP (NN PKC))) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS changes))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB previously)) (VP (VBN identified))))) (. .)))
(S1 (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (CD two) (JJ inflammatory) (NNS agents)) (, ,) (NP (NP (NN IL-1beta)) (CC and) (NP (NN phorbol) (JJ myristic) (NN acetate))) (, ,)) (S (VP (TO to) (VP (VB activate) (NP (NP (NN PKC) (NNS isozymes)) (CC and) (NP (NP (JJ specific) (NNS inhibitors)) (PP (IN of) (NP (NP (NP (NN PKCalpha)) (PRN (-LRB- -LRB-) (NP (NN Go6976)) (-RRB- -RRB-))) (CC and) (NP (NP (NN PKCbeta)) (PRN (-LRB- -LRB-) (NP (NN hispidin)) (-RRB- -RRB-)))))))))) (S (VP (TO to) (VP (VB distinguish) (SBAR (WHADVP (WRB how)) (S (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NN isoform-LRB-s-RRB-)))) (VP (VBZ controls) (NP (NP (NN angiogenesis)) (, ,) (NP (NN wound) (NN healing)) (, ,) (CC and) (NP (NN permeability)))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT all) (NNS cases))) (, ,) (NP (NP (RB only) (NN inhibition)) (PP (IN of) (NP (NN PKCalpha)))) (VP (VBD inhibited) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS functions)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN PKCbeta)))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Additional) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NP (NP (NN Go6976)) (PRN (-LRB- -LRB-) (NP (NP (NN RT-PCR)) (, ,) (NP (NN Western) (NNS blots)) (, ,) (CC and) (NP (NN immunohistochemistry))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ phosphorylated)) (CC and) (ADJP (JJ nonphosphorylated))) (NNS forms)) (PP (IN of) (NP (NN PKCalpha))))) (PP (IN in) (NP (NP (DT the) (NN cell) (NN membrane)) (CC and) (NP (NN cytoplasm))))))))))))) (VP (VBD confirmed) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN PKCalpha) (NN inhibition)) (PP (IN by) (NP (NN Go6976)))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS studies)) (ADVP (RB therefore)) (VP (VBP indicate) (NP (NP (DT a) (ADJP (ADJP (JJ specific)) (CC and) (ADJP (NN a) (JJ regulatory))) (NN role)) (PP (IN of) (NP (DT the) (NN PKCalpha) (NN isoform))) (PP (IN in) (NP (NP (CD three) (JJ major) (JJ endothelial) (NN cell) (NNS functions)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (JJ microvascular) (NN homeostasis)))))))))))))) (. .)))
